Cognitive dysfunction in schizophrenia: Maze-solving behavior in treated and untreated patients

CNS Spectrums

Volumn 2, Issue 8, 1997, Pages 26-40

  Gallhofer, B ^a   Krieger, S ^a   Lis, S ^a   Hargarter, L ^a   Roder, C ^a   Lammers, C ^a   Meyer Lindenberg, A ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002741311     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900005010     Document Type: Review

References (31)

1. Iacono WG, Tuason VB, Johnson RA. Dissociation of smooth-pursuit and saccadic eye tracking in remitted schizophrenics: an ocular reaction time task that schizophrenic perform well. Arch Gen Psychiatry. 1981;38:991-996.
2. Iacono WG, Moreau M, Beiser M, Fleming JA, Lin TY. Smooth pursuit eye tracking in first-episode psychotic patients and their relatives. J Abnorm Psychology. 1992;101:104-116.
3. Grawe RW, Lavander S. Smooth pursuit eye movements and neuropsychological impairments in schizophrenia. Acta Psychiatr Scand. 1995;2:108-114.
4. Franke P, Maier W, Hardt J, Frieboes R, Lichtermann D, Hain C. Assessment of frontal lobe functioning in schizophrenia and unipolar major depression. Psychopathology. 1993;26:76-84.
5. Winocur A, Moscovitch M. Hippocampal and prefrontal cortex contribution to learning and memory: analysis of lesion and aging effects on maze learning in rats. Behav Neurosci. 1990;104:544-551.
6. Milner B. Visually guided maze learning in man: effects of bilateral hippocampal, bilateral frontal, and unilateral cerebral lesions. Neuropsychologia. 1965;3:317-338.
7. Canavan AGM. Stylus-maze performance in patients with frontal lobe lesions: effects of signal valency and relationship to verbal and spatial abilities. Neuropsychologia. 1983;21:375-382.
8. Karnath HO, Wallesch CW, Zimmermann P. Mental planning and anticipatory processes with acute and chronic frontal lobe lesions: a comparison of maze performance in routine and non-routine situations. Neuropsychologia, 1991;29:271-290.
9. Porteus SD. Porteus Maze Test: Fifty Years' Application. Palo Alto, California: Pacific Publishers; 1965.
10. Porteus SD, DeMonbrun R, Kepner MD. Mental changes after bilateral prefrontal leucotomy. Genet Psychol Monogr. 1944;29:23-115.
11. Joel D, Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 1994;63:363-379.
12. Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 1994;6:358-370.
13. Rolls ET. Neurophysiology and cognitive functions of the striatum. Rev Neurol (Paris). 1994;150:648-660.
14. Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull. 1984;10:160-203.
15. Oswald WD, Fleischmann UM. Nurnberger Alters-Inventar (NAI). Institute of Psychology, University of Erlangen-Nurnberg, 1986. (test instrument)
16. Overall JE, Gorham DR. Brief psychiatric rating scale. Psychol Rep. 1962;10:799-812.
17. Mungas D, Magliozzi JR, Laubly JN, Blunden D. Effects of haloperidol on recall and information processing in verbal and spatial learning. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:181-193.
18. Baldessarini R, Frankenburg FR. Clozapine: a novel antipsychotic drug. N Engl J Med. 1991;324:746-754.
19. Goldberg TE, Greenberg RD, Griffin SJ, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry. 1993;162:43-48.
20. Meltzer HY. Dimensions of outcome with clozapine. Br J Psychiatry. 1992;160:46-53.
21. Mesotten F, Suy E, Pietquin M, Burton P, Heylen S, Gelders Y. Therapeutic effect and safety of increasing doses of risperidone (R64766) in psychotic patients. Psychopharmacology. 1989;99:445-449.
22. Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H. Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol. 1996;6:14-20.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Press; 1987.
24. Meyer-Lindenberg A, Gruppe H, Bauer U, Lis S, Krieger S, Gallhofer B. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry. In press.
25. Andreasen NC: Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39:784-788.
26. Abbruzzese M, Bellodi L, Ferri S, Scarone S. Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cogn. 1995;27:202-212.
27. Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH. Further evidence for dementia of the prefrontal type in schizophrenia: a controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 1987;44:1008-1014.
28. Green MF, Satz P, Ganzell S, Vaclav JF. Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit. Am J Psychiatry. 1992;149:62-67.
29. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry. 1988;153:437-443.
30. Frith CD, Done DJ. Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action. Psychol Med. 1989;19:359-363.
31. Cushman L, Caplan B. Multiple memory systems: evidence from stroke. Percept Mot Skills. 1987;64:571-577.